Clinical Trial Update: Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated safety, pharmacokinetics, and efficacy of vaginally administered Proellex for uterine fibroids, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids | Phase 2 | Status: COMPLETED | Results posted: 2014-08-29